Neoplasia/BPH

	Association between short-term radiation-induced toxicity and oncological outcomes in high-risk prostate cancer: a retrospective single-centre cohort study. Acta Oncol Kahlmeter Brandell J, Valachis A, Ugge H, Smith D, Johansson B. PMID: 41870228 [PubMed - indexed for MEDLINE]
	Minimally invasive treatments for benign prostatic hyperplasia: A narrative review. Medicine (Baltimore) Zhang X, Liang T, Dong Y, Gao H. PMID: 41870215 [PubMed - indexed for MEDLINE]
	Patterns of Supplement Use in Prostate Cancer Survivors: A Cross-Sectional Survey. Ir Med J Shine C, Johnston KE, Cushen SJ. PMID: 41869938 [PubMed - indexed for MEDLINE]
	Investigation of non-visible haematuria in a tertiary urology service. Ir Med J O'Mahony CJ, Low E, Lynch OE, Daly K, D'Arcy F, Dowling C. PMID: 41869919 [PubMed - indexed for MEDLINE]
	Nanomedicine Targeting Cancer-Associated Fibroblasts in Prostate Cancer: From Biological Mechanisms to Integrated Theranostic Strategies. Int J Nanomedicine Qian F, Zhou J, Tang Y, Chen J, Zuo J, Gou K, Tan C, Fang J, Zhao Z, Zhao J, Wen L, Fu S, Yang J, Wang C, Zhang Z. PMID: 41869404 [PubMed - indexed for MEDLINE]
	Gold Nanoparticles in Bladder Cancer Applications: A Paradigm Shift from Diagnostic Tools to Integrated Theranostic Platforms. Int J Nanomedicine Zhang X, Wu X, Du J, Mei J, Chen F, Lou K. PMID: 41869400 [PubMed - indexed for MEDLINE]
	Cause-specific mortality beyond prostate cancer in young men: a population-based study of second malignancies and non-tumor causes. Am J Transl Res Kang Y, Liu J, Lin Y, Pang L. PMID: 41868909 [PubMed]
	Identification of risk factors for the development and prognosis of bone metastases in renal cell carcinoma: development and validation of a predictive model. Am J Cancer Res Zeng W, Wu Z, Sun Y, Ma M, Fan A, Liu Z, Luo S. PMID: 41868662 [PubMed]
	Phellinus linteus polysaccharides inhibit castration-resistant prostate cancer progression possibly via dual modulation of PIK3R1 and PGC-1Î±: a preclinical evaluation. Am J Cancer Res Wei W, Huang J, Xie L, Xu Z, Lin C, Chen M. PMID: 41868659 [PubMed]
	Research progress on the intrinsic link between the occurrence and progression of malignant tumors, chronic kidney disease and drug safety. Am J Cancer Res Zhang D, Jiang S, Liu L, Lu J, Li W. PMID: 41868657 [PubMed]
	Diagnostic Value of Multiparametric Transrectal Ultrasound in Patients with Suspected Carcinoma of Prostate: A Tertiary Care Centre Experience. Indian J Radiol Imaging Chowhan PS, Gorsi U, Mavuduru R, Lal A, Mete UK, Kakkar N. PMID: 41867289 [PubMed]
	NICE 2026 guideline for the diagnosis and management of kidney cancer. Lancet Oncol Stewart GD, Boyce S, Harrisingh MC, Crane O, NICE Kidney Cancer Guideline Committee Members. PMID: 41865753 [PubMed - as supplied by publisher]
	DaBlaCa-13 Study: Five-year Follow-up from the Randomized Controlled Trial of Chemoresection with Intravesical Mitomycin C in Recurrent Ta Non-muscle-invasive Bladder Cancer. Eur Urol Oncol Klingenberg S, Lindgren MS, Jakobsen JK, Jensen JB, Kingo PS. PMID: 41864769 [PubMed - as supplied by publisher]
	Re: Hiroshi Kitamura, Taiji Tsukamoto, Yoshiyuki Kakehi, et al. Active Surveillance Versus Intravesical Bacillus Calmette-GuÃ©rin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.01.008. Eur Urol Contieri R, Lazzeri M, Perdonà S, Hurle R. PMID: 41864760 [PubMed - as supplied by publisher]
	Reply to Roberto Contieri, Massimo Lazzeri, Sisto PerdonÃ , and Rodolfo Hurle's Letter to the Editor re: Kitamura, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-GuÃ©rin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008. Eur Urol Kitamura H, Nishiyama H. PMID: 41864759 [PubMed - as supplied by publisher]
	Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study. Int J Radiat Oncol Biol Phys Anger E, Supiot S, Josset Q, Pasquier D, Vaugier L, Riet FG, Pointreau Y, Ruffier A, Loos G, Terlizzi M, Blanchard P, Martin E, Sargos P, Guerni M, Schick U, Bera G, Roman J, Latorzeff I, Créhange G, Castelli J, Barateau A, De Crevoisier R, Nicosia L, Guévelou JL. PMID: 41864432 [PubMed - as supplied by publisher]
	Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study. J Am Acad Dermatol Chen YJ, Liu WT, Yang CC. PMID: 41864295 [PubMed - as supplied by publisher]
	Editorial Comment on "A Practical Phenotyping Framework for Male LUTS Using Remote Multi-Day Urinary Diagnostics". Urology Te AE. PMID: 41864286 [PubMed - as supplied by publisher]
	Endothelial SMAD1-MCAM axis facilitates sunitinib resistance and progression of clear cell renal cell carcinoma via LAMB1-ITGB1 signaling. Drug Resist Updat Zhang H, Liu Y, Zhang W, Guo Y, Lin A, Jin Y, Lu P, Fang Y, Zhang H, Qu L, Luo P, Wu L, Chen Y, Kang X, Wang L, Jiang A. PMID: 41864072 [PubMed - as supplied by publisher]
	Hematuria-related readmission after transurethral resection of bladder tumor in patients receiving antiplatelet therapy. Urologia Ilktac A, Dogan B, Gevher F, Akcay M, Akbulut H, Ilbey YO. PMID: 41863856 [PubMed - as supplied by publisher]

Articles 1 - 20 / 186518

Page 1 of 9326



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy